Second SGLT2 Drug Scores for HFrEF, Regardless of Diabetes Status EMPEROR-Reduced trial "exceptionally concordant" with DAPA-HF results Aug 28, 2020
FDA Drops Boxed Warning From Invokana Label Amputation risk "lower than previously described" Aug 27, 2020
Diabetes Drugs Looking for Broad Role in COVID-19 The mechanisms check out and trials are underway Aug 24, 2020
Healthy People 2030: HHS Prioritizes Socioeconomic Disparities, Overall Well-Being New national health goals for the next decade Aug 20, 2020
DPP-4 Inhibitors Tied to Blistering Skin Condition Increased risk for bullous pemphigoid modified by patient age, race Jul 22, 2020
A Diabetes Drug That Slows Cognitive Decline? Trulicity analysis hints at dementia prevention Jun 22, 2020
Ertugliflozin Tx: Safe for the Heart in Patients With T2D Phase III VERTIS-CV trial meets primary endpoint of MACE non-inferiority Jun 17, 2020
NDMA Prompts Metformin Recall FDA finds certain products with excessive levels of potential carcinogen May 29, 2020
Drugs Helped Stop Weight Regain After Gastric Bypass Half of patients in retrospective study regained a third of lost weight May 27, 2020
Miscarriage: Predictive of Type 2 Diabetes? Whether such a link is due to underlying metabolic conditions, however, is still to be determined May 21, 2020
An Argument for Losing Weight Prior to Bariatric Surgery Study suggests reduction in already low mortality risk May 14, 2020
Cold-Induced Energy Burn Higher With Brown Fat More evidence of the tissue's potential as target for weight loss, researchers say Apr 28, 2020
Metformin Appears to Shield Diabetic Patients From Post-Op Death Similar to statins, with anti-inflammatory properties suggested as explanation Apr 09, 2020
Minimally Invasive DMR Scores a Win in T2D Outpatient duodenal mucosal resurfacing procedure showed broad range of metabolic benefits Mar 31, 2020
Higher On-Tx EPA Levels Explain Benefit of Vascepa Further evidence from REDUCE-IT that triglyceride lowering is not key to icosapent ethyl's effects Mar 30, 2020
NKF 2020: New Lupus Tx; Staying on Spironolactone, and More Research highlights from the National Kidney Foundation virtual meeting Mar 30, 2020
TWILIGHT Findings Hold Strong in Diabetes, Complex PCI Ticagrelor monotherapy after brief DAPT also worked following newer-gen stent implantation Mar 30, 2020
Ultra-Processed Foods: It's Not Just Sugar and Fat Attacking Waistlines The Skeptical Cardiologist reviews the evidence Mar 07, 2020
Workplace Wellness Program Triumphs for Hypertension Two-thirds meet blood pressure target after 2 years Mar 04, 2020
Diabetes Drug May Benefit Long-Term Steroid Users Metformin improved metabolic profile in patients with chronic inflammatory disease Feb 25, 2020
What Lorcaserin Did for Me Journalist who used weight-loss drug for a year -- and lost a lot of weight -- reflects on the recent news Feb 14, 2020
Entresto Data Support Wider Reach of 'Fifth Pillar' HF Drug Benefits observed beyond HF patients with reduced EF Nov 17, 2019
Apabetalone Falls Short in Patients With T2D and ACS Trial of BET protein inhibitor likely underpowered to show benefit Nov 17, 2019
HF Benefit of Dapagliflozin Affirmed in Non-Diabetics Fewer CV events for heart failure with reduced ejection fraction Nov 16, 2019
Time to Rethink BMI Cutoff for Bariatric Surgery? The point isn't weight loss, researcher argues, but treatment for diabetes, hypertension, and other comorbidities Nov 06, 2019
Why the Lower Risk of Prostate Cancer in Men With Diabetes? Findings from large cohort study do not support one leading hypothesis, researchers say Nov 06, 2019
The 'Bedtime Snack' for Inmates With Diabetes Where do they get the idea that it's standard medical care? Oct 24, 2019
Dapagliflozin: More Good News in HF SGLT-2 inhibitor advantage in DAPA-HF extended across T2D status, ARNI use Sep 19, 2019
Bariatric Surgery Tied to Better Cardiometabolic Health Down the Road Improvements beyond risk factor reduction in patients with T2D and obesity Sep 02, 2019
Dapagliflozin Benefits HFrEF Outcomes, Even Without Diabetes DAPA-HF trial affirms similar benefit to diabetes drug regardless of type 2 diabetes status Sep 01, 2019 video
Extended DAPT with Brilinta: No Benefit for Stable CAD in T2D Substudy in those with prior PCI might identify group where bleeding tradeoff is worthwhile Sep 01, 2019
Osteoporosis Drug Wins; Tramadol and Blood Sugar News and commentary from the endocrinology world Aug 30, 2019
GLP-1 RA Benefits Extend Beyond MACE Reduction Meta-analysis pooled data on all major outcomes trials for agent class Aug 16, 2019
No Added CV Risk for Oral Semaglutide in T2D Safety study buffs resume for oral GLP-1 receptor agonist Jun 11, 2019
Urine Marker Predicts Kidney Benefit With Trulicity Secondary AWARD-7 analysis finds subgroup getting the most renal protection Jun 11, 2019
Dapagliflozin Boosts Renal Function in T2D Secondary outcomes build on previously reported cardiovascular benefit from SGLT2 inhibitors Jun 10, 2019
Another GLP-1 Agent Cuts Heart Risk in T2D Dulaglutide added to the growing list of diabetes treatments to show added benefit Jun 10, 2019
Novel Anti-CD3 Antibody Delays Progression to T1D Single course of teplizumab slowed march to clinical type 1 diabetes in high-risk people Jun 09, 2019
Expert Panel Defines CGM Time-in-Range Targets Seventy percent of readings should stay between 70-180 mg/dL, according to recommendations Jun 09, 2019
